28 October: GLP-1 receptor agonists, New Product Evaluations, & PGD template updates

21 October: Prescribing Outlook, Golimumab Biosimilar, & CPC North

Primary care discussions: biosimilar insulin

16 September: time critical use of rasburicase, biosimilars, & upcoming events

Understanding safe use of medicines challenges in palliative and end of life care

Primary biliary cholangitis (PBC)

Autoimmune hepatitis (AIH)

Metabolic dysfunction associated steatotic liver disease (MASLD)

MSATS: People living with diabetes and what insulin safety means to them

Unlicensed medicines: good practice principles

Primary care discussions: personalised evidence-based medicine to minimise polypharmacy

MSATS: Voice of people living with diabetes - insulin safety and visual impairment

MSATS: Insulin safety considerations in Health and Justice and secure settings

Unlicensed medicines: information, assurance, & diligence

Unlicensed medicines: why we need them

Lipid management and newer therapies

Swallowing difficulties (part one)

Swallowing difficulties (part two)

Pharmacy First: Infected Insect Bites

Pharmacy First: Impetigo